
    
      This is a randomized double-blind clinical trial comparing 2.5mg of oral Dronabinol daily
      starting with pre-op cocktail and continued twice daily for three days after surgery versus
      placebo for patients aged 18 to 65 years old undergoing 1 to 3 level posterolateral fusion.
      The outcome of interest is post-operative opioid consumption defined as cumulative Morphine
      Milligram Equivalents at 72 hours after surgery.
    
  